MIR5687

Across TCGA pan-cancer cohorts, MIR5687 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR5687 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher MIR5687 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR5687 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LIHC show a favorable association.

UVM, BRCA, and THCA are the cancer types where MIR5687 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	II,III,IV	0.218	0.718	.006	72	view →
BRCA	DFS	Tertile	All	0.727	0.911	<.001	72	view →
THCA	DFS	Tertile	IV	0.144	0.884	<.001	54	view →
CESC	DFS	Tertile	II,III,IV	0.178	0.790	<.001	54	view →
READ	DFS	Tertile	II,III,IV	0.059	0.818	<.001	36	view →
ESCA	DFS	Quartile	III,IV	0.582	0.285	.024	21	view →
UCEC	OS	Tertile	IV	0.308	0.748	.009	18	view →
STAD	DFS	Quartile	All	0.441	0.586	.022	8	view →
LIHC	OS	Tertile	II,III,IV	1.000	0.367	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR5687–UVM (OS)

Open the UVM breakdown →